Site 5112, David Geffen School of Medicine at UCLA — Los Angeles, California

Site 5112, David Geffen School of Medicine at UCLA is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 5112, David Geffen School of Medicine at UCLA has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV-1.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 5112, David Geffen School of Medicine at UCLA?

Site 5112, David Geffen School of Medicine at UCLA has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 5112, David Geffen School of Medicine at UCLA conducted?

Site 5112, David Geffen School of Medicine at UCLA has 1 clinical trials on record, with 1 currently active. Their work covers HIV-1.

Is Site 5112, David Geffen School of Medicine at UCLA accredited by Crixeo Health?

Site 5112, David Geffen School of Medicine at UCLA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 5112, David Geffen School of Medicine at UCLA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.